CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

NCT01760811 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Erbitux,merck serono

Sponsor

Rabin Medical Center

Collaborators

[object Object]
[object Object]